Article Information
History
- December 25, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Neil Bate1,2,
- Christos G Savva3,
- Peter CE Moody3,
- Edward A Brown3,
- Jonathan K Ball4,
- John WR Schwabe3,
- Julian E Sale5 and
- Nicholas PJ Brindle1,2,*
- 1Department of Molecular & Cell Biology, University of Leicester, University Road, Leicester, Leicester LE1 7RH UK
- 2Department of Cardiovascular Sciences, University of Leicester, University Road, Leicester, Leicester LE1 7RH UK
- 3Leicester Institute of Structural and Chemical Biology, Department of Molecular and Cellular Biology, University of Leicester, University Road, Leicester, LE1 7RH, UK
- 4School of Life Sciences, The University of Nottingham, Nottingham NG7 2UH, UK
- 5Division of Protein & Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, CB2 0QH, UK
- ↵*Corresponding author
Nicholas PJ Brindle, Dept Molecular & Cell Biology, University of Leicester, University Road, Leicester, LE1 7RH UK, Email: NPJB1{at}Le.ac.uk, Tel: +44(0)116 229 7170
Posted December 25, 2021.
In vitro evolution predicts emerging CoV-2 mutations with high affinity for ACE2 and cross-species binding
